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for the repair of articular cartilage defects
C. Vinatier1, O. Gauthier2, M. Masson3, C. Merceron4, A. Moreau5,
P. Weiss6, J. Guicheux2;
1Inserm U791 Lioad Laboratory Of Osteoarticular And Dental Tissue 
Engineering, University of Nantes, nantes, France, 2Inserm U791, 
Laboratory Of Osteoarticular And Dental Tissue Engineering, 
University of Nantes, Nantes, France, 3Laboratory Of Osteoarticular 
And Dental Tissue Engineering, Inserm U791, University of Nantes, 
Nantes, France, 4Research Center On Osteoarticular And Dental 
Tissue Engineering, UMR S/Inserm U791, Nantes, France, 5Anatomo-
cytopathology, university hospital, Nantes, France, 6Inserm U791 
Laboratory Of Osteoarticular And Dental Tissue Engineering, 
university of Nantes, Nantes, France
Purpose: Articular cartilage has low capacities for spontaneous 
SFQBJS5PQSPNPUFUIFSFQBJSPGUIJTUJTTVFBNQMJ¾DBUJPOBOEUSBOTGFS
of autologous chondrocytes using a three-dimensional matrix appear 
promising. In this attempt, we developed a self-setting and three-
dimensional matrix consisting in a silanized cellulose derivative (Si-
HPMC). In previous works, we showed that our hydrogel enabled the 
proliferation of human and rabbit chondrocytes, the production of 
sulfated GAG and the expression of the main chondrocytic markers 
during a three-dimensional culture in vitro. In parallel, the capacity of 
our hydrogel to allow the formation of a cartilaginous tissue in vivo 
was determined by transplantation of human nasal chondrocytes 
and Si-HPMC in subcutaneous pockets in nude mice. Therefore, we 
sought to evaluate the preclinical interest of autologous chondrocyte 
transplantation with Si-HPMC in rabbit articular cartilage defects. 
Methods and Materials: "GUFSIBSWFTUJOHBOEBNQMJ¾DBUJPOEVSJOH
weeks, nasal autologous rabbit chondrocytes were transplanted with 
Si-HPMC in critical-size defects created in rabbit articular cartilage. 
Implants were histologically characterized for the presence of sulfated 
GAG (Alcian blue staining) and collagen (Masson’s trichrome staining). 
The presence of type II collagen was investigated by immunostaining. 
Results: After a 6-week implantation, histological analysis of 
implants revealed the formation of a repair tissue exhibiting a 
histological organization similar to that of healthy articular cartilage 
with a positive staining for sulfated GAG and total collagen. 
Immunohistological analysis of type II collagen showed that the 
repair tissue was hyaline-like cartilage. 
Conclusions: Our results indicate that Si-HPMC hydrogel appears a 
potential scaffold for the cellular therapy of articular cartilage. 
P210
Effect of cell number on the quality of the repair tissue in Autologous 
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Purpose: Until now it is still unclear if the number of implanted cells 
in autologous chondrocyte implantation (ACT) has an effect on the 
quality of the repair tissue. To address this issue we performed ACT 
with different cell numbers in an in-vivo model of human articular 
defects. 
Methods and Materials: Human full-thickness (2-4mm) articular 
cartilage discs, 10mm in diameter, attached approximately 3mm of 
subchondral bone, were obtained from human femoral heads upon 
joint replacement. Chondral defects (2 and 4 mm in diameter) were 
set without violating subchondral bone. Human chondrocytes derived 
from femoral heads were isolated and cultivated for up to 3 passages. 
5IFEFGFDUXBTDPNQMFUFMZ¾MMFEXJUIBDFMMTVTQFOTJPOPGFJUIFS6
or 107 cells/ml and cells were allowed to adhere to the cartilage inner 
TVSGBDF%FGFDUTXFSFDPWFSFEXJUIIVNBOQFSJPTUFVN¾YFEXJUIB
ESPQPG¾CSJOTFBMBOU%JTDTXFSFJNQMBOUFETVCDVUBOFPVTMZJOUIF
back of nude mice for 5 and 8 weeks. The repair tissue was evaluated 
by histology with analysis of cell number, cell morphology, spatial 
orientation and production of extracellular matrix. 
Results: The concentration of 107 DFMMT SFTVMUFE JO TJHOJ¾DBOU
increase in the quality of repair tissue over time with differentiated 
chondrocytes in chondron-like structures and formation of 
proteoglycane-rich extracellular matrix. In comparison the samples 
XJUIMPXFSDFMMOVNCFSTSFWFBMFE¾CSPVTPS¾CSPIZBMJOFUJTTVFXJUI
less differentiated chondrocytes and extracellular matrix. 
Conclusions: The quality of the repair tissue after ACT in respect of 
cell differentiation and formation of proteoglycane-rich extracellular 
NBUSJYJTTJHOJ¾DBOUMZEFQFOEFOUPOUIFOVNCFSPGJNQMBOUFEDFMMT
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Purpose: The principle of matrix associated autologous chondrocyte 
transplantation (MACT) is to deliver chondrocytes associated with 
a biomaterial to the cartilage defect. Up to now it is still a question 
to which extent cells from the surrounding tissues participate to the 
¾OBMSFQBJSUJTTVF*OPSEFSUPJOWFTUJHBUFUIFBNPVOUPGDFMMTJOWBEJOH
the transplants, horses were treated with cell-free MACT-scaffolds. 
Methods and Materials: Cell-free biomaterials as a collagen type 
I gel (CaReS®), a collagen type I/III membrane (Biogide®), and a 
hyaluronan scaffold (Hyalograft®C) were implanted into the lateral 
facette of the femoropatellar joint of two horses. The regenerative 
tissue was taken 1.5 years after implantation and analysed by 
histochemical, immunhistochemical, ultrastructural methods and 
element analysis (EDAX). 
Results: *OBMMEFGFDUT¾CSPVTUJTTVFXBTGPSNFE5IFNBUSJYTIPXFE
a certain degree of cartilage-like organisation such as the vertical 
PSJFOUBUJPOPGDPMMBHFO¾CSFTBOEBTVQFS¾DJBMMBZFSPGMVCSJDJOMJLF
granular material. However, the tissue was negative for collagen 
UZQF ** BOE QPPS JO QSPUFPHMZDBOT 5IFNBUSJYXBTXFMM JO¾MUSBUFE
by cells which sometimes showed signs of differentiation such as 
spherical cell morphology and a pericellular matrix. Both, regular 
and uneven cell-distribution were observed. Signs of cell invasion 
were found at the border to the native cartilage as well as at the 
transplant surface. 
Conclusions: The results of the cell-free scaffold implantation showed 
that invading cells strongly participate to tissue formation. The 
formed tissue is not hyaline-like and non-uniform. The implantation 
of cell-free scaffolds cannot be used for cartilage repair in the horse 
model. 
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Purpose: The aim was to develop an optimal transport system for 
tissue engineered constructs. 
Methods and Materials: Chondrocytes were isolated, culture 
expanded and seeded in Hyaff-11 scaffolds. After 14 days of culture 
the constructs were packed in a transport system. The primary 
packing consisted of a 2-container system that assures the viability 
and sterility. The secondary packaging was a plastic cylinder 
approved for transport of biohazards material. The outer packaging 
consisted of a polystyrene box and gel packs. The boxes were then 
placed in ambient temperature on a shaking plate for 48h. During 
the 48 hours the box was also turned up side down three times to 
mimic a real transport situation After the simulated 48 hour transport 
the constructs were tested for handling properties, viability and its 
histoarchitecture. 
Results: No difference in handling properties of the constructs was 
seen between before and after the 48 hours simulated transport. 
All constructs were stable and showed no signs of disruption. The 
viability was controlled by staining the constructs with a Live-Dead 
staining. Only viable cells (green) was seen and no signs of dead 
cells. There was no difference before or after the simulated transport. 
The Histology showed cells through the whole membrane and matrix 
production within the membrane and no disruption of the construct. 
No difference was seen before and after the simulated transport. 
Conclusions: We show that we have a transport system that ensures 
a good transport of the tissue engineered construct between the 
GMP laboratory and the hospital. 
